Every figure this model derived for RXST, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.
This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.
| Figure | Value | XBRL tag | As at |
|---|---|---|---|
| capex | 4,433,000 | PaymentsToAcquirePropertyPlantAndEquipment |
2026-06-30 |
| cash | 208,799,000 | CashAndCashEquivalentsAtCarryingValue |
2026-06-30 |
| current assets | 327,396,000 | AssetsCurrent |
2026-06-30 |
| current liabilities | 80,444,000 | LiabilitiesCurrent |
2026-06-30 |
| equity | 263,340,000 | StockholdersEquity |
2026-06-30 |
| interest expense | 15,000 | InterestExpense |
2026-06-30 |
| ocf | -22,732,000 | NetCashProvidedByUsedInOperatingActivities |
2026-06-30 |
| revenue | 121,082,000 | RevenueFromContractWithCustomerExcludingAssessedTax |
2026-06-30 |
| sbc | 31,335,000 | ShareBasedCompensation |
2026-06-30 |
The figures themselves rather than their scores — what somebody looking up RXST on one particular measure came for.
| Ratio | Value |
|---|---|
| cash operating margin | -16.72 |
| current ratio | 4.45 |
| current ratio reported | 4.07 |
| deferred revenue growth | 15.76 |
| dilution pct | 5.11 |
| fcf margin | -22.44 |
| growth cv | 0.65 |
| interest cover | -3674.27 |
| operating margin | -45.52 |
| owner earnings margin | -48.31 |
| revenue growth | -17.66 |
| revenue growth per share | -21.66 |
| roic | -79.71 |
| rule of 40 | -63.18 |
| sbc pct revenue | 25.88 |
What this model itself distrusts about RXST's figures. Written by the derivation as it ran, not added afterwards.